Cognitive decline in women in relation to non-protein-bound oestradiol concentrations
- 1 August 2000
- journal article
- clinical trial
- Published by Elsevier BV in The Lancet
- Vol. 356 (9231), 708-712
- https://doi.org/10.1016/s0140-6736(00)02628-3
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Serum Estrogen Levels, Cognitive Performance, and Risk of Cognitive Decline in Older Community WomenJournal of the American Geriatrics Society, 1998
- The effect of short-term estrogen replacement therapy on cognition: A randomized, double-blind, cross-over trial in postmenopausal women*1Published by Ovid Technologies (Wolters Kluwer Health) ,1998
- Cognitive function in nondemented older women who took estrogen after menopauseNeurology, 1998
- A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's diseaseNeurology, 1997
- Effect of oestrogen during menopause on risk and age at onset of Alzheimer's diseaseThe Lancet, 1996
- Risk Factors for Hip Fracture in White WomenNew England Journal of Medicine, 1995
- Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer's Disease: A Population-based Case-Control StudyAmerican Journal of Epidemiology, 1994
- Estrogen Deficiency and Risk of Alzheimer's Disease in WomenAmerican Journal of Epidemiology, 1994
- Postmenopausal Estrogen and Prevention BiasAnnals of Internal Medicine, 1991
- Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal womenPsychoneuroendocrinology, 1988